- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Non-small Cell Lung Carcinoma
Total 18364 results
-
Incyte CorporationZai Lab (Shanghai) Co., Ltd.Active, not recruitingMetastatic Squamous Non-Small Cell Lung Cancer | Metastatic Nonsquamous Non-Small Cell Lung CancerChina, Czechia, Russian Federation, Serbia, Malaysia, Vietnam, United States, Poland, Ukraine, Romania, Turkey, Brazil, Bulgaria, Georgia, Hungary, Philippines, South Africa
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)TerminatedStage IIIB Non-Small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)TerminatedStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)TerminatedStage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung CancerUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedStage I Non-Small Cell Lung Cancer | Stage II Non-Small Cell Lung CancerUnited States
-
Hebei Medical University Fourth HospitalUnknownNon-small Cell Lung Cancer Stage ⅢA | Non-small Cell Lung Cancer Stage ⅡChina
-
National Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
Juan LI, MDRecruitingNon Small Cell Lung Cancer | EGFR Exon 20 Insertion MutationChina
-
University of MiamiCompletedLung Cancer | Non Small Cell Lung Carcinoma | HypermethylationUnited States
-
Radiotherapy Oncology Centre "Santa Maria" HospitalPaola Anselmo,MD; Michelina Casale,PhD; Ernesto Maranzano,MD; Fabio Trippa,MDCompletedLocally Advanced Lung Non-Small Cell CarcinomaItaly
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)TerminatedRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | EGFR Activating MutationUnited States
-
The Netherlands Cancer InstituteAstraZenecaRecruitingOsimertinib Resistance in Patients With Non-small-cell Lung Carcinoma That Have Progressed. (OSIRIS)Non-small-cell Lung CarcinomaNetherlands
-
University Health Network, TorontoActive, not recruitingNon-small Cell Lung CarcinomaCanada
-
European Lung Cancer Working PartyActive, not recruiting
-
European Lung Cancer Working PartyTerminatedNon-small Cell Lung CarcinomaBelgium, France, Spain, Greece
-
National Cancer Institute (NCI)NRG OncologyTerminatedStage IIIA Non-Small Cell Lung Cancer AJCC v7 | Stage III Non-Small Cell Lung Cancer AJCC v7 | Stage IIIB Non-Small Cell Lung Cancer AJCC v7United States
-
National Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)M.D. Anderson Cancer CenterTerminatedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)TerminatedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
Bristol-Myers SquibbCompletedNon-Squamous Cell Non-small Cell Lung CancerUnited States, Germany, Hong Kong, Spain, Australia, Mexico, Austria, France, Singapore, Switzerland, Canada, Poland, Argentina, Brazil, Chile, Czechia, Hungary, Italy, Norway, Peru, Romania, Russian Federation
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownAdvanced Non-squamous Cell Non-small Cell Lung CancerChina
-
Calithera Biosciences, IncTerminatedNon-Small Cell Lung Cancer | Non-squamous Non-small-cell Lung Cancer | Non-Squamous Non-Small Cell Neoplasm of Lung | KEAP1 Gene Mutation | NFE2L2 Gene Mutation | NRF2 MutationUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedStage IV Non-Small Cell Lung Cancer AJCC v7 | Stage IIIA Non-Small Cell Lung Cancer AJCC v7 | Stage III Non-Small Cell Lung Cancer AJCC v7 | Stage IIIB Non-Small Cell Lung Cancer AJCC v7United States
-
Second Affiliated Hospital, School of Medicine,...RecruitingSquamous Cell Non-small Cell Lung CancerChina
-
Peking University People's HospitalNational Natural Science Foundation of ChinaCompletedCarcinoma | Lung Neoplasms | Non-small-cell Lung CancerChina
-
Eckhard PodackWithdrawnNon-Small Cell Lung Cancer | NSCLC | Lung Cancer | Non-small-cell Lung Carcinoma
-
Jonsson Comprehensive Cancer CenterEli Lilly and Company; Genentech, Inc.RecruitingMetastatic Lung Non-Small Cell Carcinoma | Refractory Lung Non-Small Cell Carcinoma | Stage IV Lung Cancer American Joint Committee on Cancer (AJCC) v8 | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8United States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingMetastatic Lung Non-Small Cell Carcinoma | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Advanced Lung Non-Small Cell CarcinomaUnited States
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingStage IIIA Lung Non-Small Cell Cancer AJCC v7 | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage III Lung Non-Small Cell Cancer AJCC v7United States, Canada
-
Gilead SciencesArcus Biosciences, Inc.RecruitingLung Cancer | Advanced or Metastatic Non-Small-Cell Lung Cancer | Resectable Non-Small-Cell Lung CancerUnited States, Korea, Republic of, Taiwan, Hong Kong, Israel, United Kingdom
-
Xuanzhu Biopharmaceutical Co., Ltd.RecruitingROS1 Rearrangement Non-small Cell Lung Cancer | ALK Rearrangement Non-small Cell Lung CancerChina
-
Shanghai Chest HospitalRecruitingNon-small Cell Lung Cancer Metastatic | EGF-R Positive Non-Small Cell Lung CancerChina
-
Washington University School of MedicineEli Lilly and CompanyActive, not recruitingNSCLC | Non Small Cell Lung Cancer | Non-small Cell Lung CancerUnited States
-
Royal Marsden NHS Foundation TrustBristol-Myers SquibbActive, not recruitingNon-small Cell Lung Cancer Stage I | Non-small Cell Lung Cancer Stage IIUnited Kingdom
-
Alliance Foundation Trials, LLC.AstraZenecaActive, not recruitingStage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung CancerUnited States
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...Regione LombardiaCompletedNon-small Cell Lung Cancer Stage IIIB | Non-small Cell Lung Cancer Stage IVItaly
-
Maastricht Radiation OncologyUniversity Medical Center Groningen; The Netherlands Cancer InstituteCompletedNon Small Cell Lung Cancer (NSCLC) | Stage III Non-Small Cell Lung Cancer | Radical TreatmentNetherlands
-
QLT Inc.TerminatedStage IV Non-small Cell Lung Cancer | Stage IIIb Non-small Cell Lung Cancer
-
QLT Inc.TerminatedStage IV Non-small Cell Lung Cancer | Stage IIIb Non-small Cell Lung Cancer
-
City of Hope Medical CenterNational Cancer Institute (NCI); CytoImmune TherapeuticsRecruitingMetastatic Lung Non-Small Cell Carcinoma | Refractory Lung Non-Small Cell Carcinoma | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage IIIC Lung Cancer... and other conditionsUnited States
-
Schwartzberg, Lee, M.D.AmgenCompletedNon-small Cell Lung CancerUnited States
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingA Study to Evaluate SHR-1210 in Combination With Famitinib Plus Chemotherapy in Subjects With NSCLC.Non-squamous Non-small-cell Lung CancerChina
-
National Hospital Organization Nagoya Medical CenterMerck Sharp & Dohme LLC; Central Japan Lung Study GroupActive, not recruitingNon-squamous Non-small-cell Lung Cancer | Cancer, LungJapan
-
AbbVieCompletedNon-squamous Non-small Cell Lung CancerUnited States, Argentina, Australia, Canada, Czechia, Denmark, Finland, Germany, Hungary, Israel, Japan, Korea, Republic of, Netherlands, New Zealand, Russian Federation, South Africa, Spain, Taiwan, Turkey, United Kingdom
-
The First Affiliated Hospital with Nanjing Medical...UnknownNon-squamous Non-small-cell Lung Cancer